Skip to main content
Kenneth Davis, MD, Psychiatry, New York, NY, The Mount Sinai Hospital

KennethDavisMD

Psychiatry New York, NY

Geriatric Psychiatry, Neuropsychiatry, Psychopharmacology

President and Chief Executive Officer​​ of the Mount Sinai Health System and Gustave L. Levy Distinguished Professor

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Davis' full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1974 - 1976
  • Stanford Health Care
    Stanford Health CareInternship, Transitional Year, 1973 - 1974
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1973
  • Yale University
    Yale UniversityB.A., Magna Cum Laude, 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1974 - Present
  • NY State Medical License
    NY State Medical License 1980 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • George H.W. Bush '48 Lifetime of Leadership Award – a distinction given to Yale alumni athletes who make significant breakthroughs in their professions Yale University, 2009
  • "Man of the Year" Award Genetic Disease Foundation, 2007
  • Paul Hoch Distinguished Service Award American College of Neuropsychopharmacology, 2007
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Genes and proteins associated with the nodes of Ranvier affect cognition, cortical physiology, and risk of schizophrenia  
    Roussos P, Katsel P, Davis KL, Bitsios P, Giakoumaki SG, Jogia J, Rozsnyai K, Collier D, Frangou S, Siever L, Haroutunian V, Archives of General Psychiatry, 1/1/2012
  • A system level transcriptomic analysis in schizophrenia postmortem brain  
    Roussos P, Katsel P, David KL, Siever LJ, Haroutunian V, Archives of General Psychiatry, 1/1/2012
  • Molecular and genetic evidence for abnormalities in the nodes of Ravier in schizophrenia  
    Roussos P, Katsel P, Siever L, David KL, Haroutunian V, Archives of General Psychiatry, 1/1/2012
  • Join now to see all

Authored Content

  • President Trump's Budget Should Boost Rather Than Cut Funding for the NIHMay 2017
  • President Trump's Budget Should Boost Rather Than Cut Funding for the NIHMay 2017

Press Mentions

  • New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm Beach
    New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm BeachMay 15th, 2023
  • Mount Sinai Health System Recognized by Fortune as One of “America’s Most Innovative Companies 2023”
    Mount Sinai Health System Recognized by Fortune as One of “America’s Most Innovative Companies 2023”March 28th, 2023
  • Scientists Share ‘Comprehensive’ Map of Volcanoes on Venus — All 85,000 of Them
    Scientists Share ‘Comprehensive’ Map of Volcanoes on Venus — All 85,000 of ThemMarch 28th, 2023
  • Join now to see all

Grant Support

  • Project 4 - DTI And MTI Studies In SchizophreniaNational Center For Research Resources2006–2007
  • White Matter Abnormalities In SchizophreniaNational Institute Of Mental Health2002–2006
  • Project 4 - Diffusion Tension Imaging (DTI) And Magnetization Transfer ImaginNational Center For Research Resources2005
  • Project 4 - Diffusion Tension Imaging (DTI) And Magnetization Transfer Imagin...National Center For Research Resources2004
  • General Clinical Research CenterNational Center For Research Resources2003–2004
  • Facility Renovation And Annenberg CAGE WASH FacilitiyNational Center For Research Resources2003
  • Magnetization Transfer And Diffusion Tensor ImagingNational Institute Of Mental Health2002
  • Alpha 2 Agonist PLUS A Cholinesterase Inhibitor In Alzheimers DiseaseNational Institute On Aging1999–2002
  • Mental Health CRC To Study Geriatric SchizophreniaNational Institute Of Mental Health1997–2002
  • Alzheimers Disease Research CenterNational Center For Research Resources1987–2002
  • Extramural Research Facilities ConstructionNational Center For Research Resources2001
  • Alzheimers Disease Research CenterNational Institute On Aging1997–2001
  • Alzheimers DiseaseNational Institute On Aging1997–1998
  • Neurochemistry ProjectNational Institute On Aging1994–1998
  • Amyloid Beta Protein In CSF And Familial Aggregation In Alzheimer'S DiseaseNational Institute On Aging1994–1998
  • Program In Biological PsychiatryNational Center For Research Resources1995–1996
  • Alzheimers DiseaseNational Institute On Aging1994–1996
  • Cellular And Molecular Markers In SchizophreniaNational Center For Research Resources1994–1996
  • Cellular And Molecular Markers In SchizophreniaNational Institute Of Mental Health1990–1996
  • Alzheimer'S Disease Research CenterNational Center For Research Resources1992–1993
  • Noradrenergic Markers In Alzheimer'S DiseaseNational Institute On Aging1989–1993
  • Alzheimer'S Disease Research CenterNational Institute On Aging1985–1993
  • Cholinergic Treatment Of Memory Deficits In The AgedNational Center For Research Resources1985–1993
  • Competitive Supplement To ADRCNational Institute On Aging1992
  • Supplement To Alzheimer'S Disease Research CenterNational Institute On Aging1991–1992
  • Toward A Rational Use Of Plasma HVA In Mental IllnessNational Center For Research Resources1990–1991
  • Cholinergic Treatment Of Memory Deficits In The AgedNational Institute On Aging1985–1989
  • Plasma HOMA Vanillic Acid (PHVA) Use In Mental IllnessNational Center For Research Resources1985–1989
  • Drug Treatments Of Noncognitive Behavioral Disturbances In ADNational Institute On Aging1985–1988
  • Biologically Induced Human Models Of ADNational Institute On Aging1985–1988
  • Clinical And Biomedical Effects Of Neuroleptic Agents WithdrawalNational Center For Research Resources1985–1988
  • The Efficacy Of THA In Alzheimer'S DiseaseNational Institute On Aging1987
  • Toward A Rational Use Of Plasma MVA In Mental IllnessNational Institute Of Mental Health1986–1987
  • Clinical Markers/Genetic Risks In Alzheimer'S DiseaseNational Institute On Aging1986
  • RS-86 Treatment Of Alzheimer'S DiseaseNational Center For Research Resources1985–1986

Hospital Affiliations